Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
100.00%
Operating Margin
65.63%
Net Margin
106.42%

Efficiency Metrics

Revenue per Expense Ratio
-69,887,757.0
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
65.63%
Income Tax Rate
0.00%
EPS
-0.9600000000

Balance Sheet Analysis

Current Ratio
0.49
Cash Ratio
0.09
Working Capital
$-5.85M
Debt to Equity
0.27
Debt to Assets
21.44%
Equity Ratio
78.08%

Cash Flow Analysis

Operating Cash Flow Ratio
-6.92%
Free Cash Flow Ratio
-6.92%
CapEx to Revenue
0.00%
Dividends Paid
$162.39M
Stock Buybacks
$20.00M
Total Shareholder Returns
$182.39M
Cash Position Change
58.91%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
67.42%
Net Income
66.50%
EPS
69.03%
Operating Income
78.52%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
-40.22%
Operating Cash Flow
104.34%
Free Cash Flow
104.34%

Balance Sheet Health

Assets
-2.90%
Debt
4.00%
Book Value per Share
-11.93%
Inventory
-39.15%

Shareholder Returns

Dividends per Share
-0.70%
Shares Outstanding
7.80%

Long Term Trends

3Y Revenue/Share
73.89%
5Y Revenue/Share
-226.55%
3Y Dividend/Share
0.04%
5Y Dividend/Share
5.70%